Fertility warning
This medicine may affect fertility.
Leaflet CICLOFOSFAMIDA DR REDDY'S 500mg / ml concentrate for solution for injection / infusion
- Product code:
- W68691001
- Quantity:
- 1
- Indicated for:
- cancer
- Route of administration:
- injectable / infusion
- Substance:
- cyclophosphamide (alkylating antineoplastic agent)
- ATC
- L01AA01 — Antineoplastic and immunomodulating agents | Alkylating agents | Nitrogen mustard analogues
Precautions:
Dose adjustment in hepatic impairment
Dose adjustment may be needed in liver disease.
Cytotoxic / special handling
Handle with special care.
Contraception required
Effective contraception is required during treatment.
Contraindicated during breastfeeding
Do not use this medicine while breastfeeding.
Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Hepatotoxicity
This medicine may affect the liver.
Major drug interactions
This medicine may have important interactions with other medicines.
Myelosuppression / agranulocytosis
This medicine may lower blood cell counts.
Additional monitoring
This medicine is subject to additional monitoring.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Severe skin reactions
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Cyclophosphamide is a chemotherapy drug used to treat various types of cancer, including lymphomas, leukemias, and breast cancer. It belongs to the class of alkylating agents and works by destroying cancer cells and preventing them from dividing.
The medication is administered intravenously or orally, depending on the type and stage of cancer. It is often used in combination with other chemotherapy drugs to enhance treatment effectiveness.
Side effects may include nausea, vomiting, hair loss, fatigue, and an increased risk of infections. In rare cases, it may cause kidney or bladder toxicity. It is important to follow all medical recommendations to minimize risks.
Consult your doctor to discuss the benefits and risks of treatment with Cyclophosphamide. Close monitoring is essential during treatment to manage potential side effects.
The medication is administered intravenously or orally, depending on the type and stage of cancer. It is often used in combination with other chemotherapy drugs to enhance treatment effectiveness.
Side effects may include nausea, vomiting, hair loss, fatigue, and an increased risk of infections. In rare cases, it may cause kidney or bladder toxicity. It is important to follow all medical recommendations to minimize risks.
Consult your doctor to discuss the benefits and risks of treatment with Cyclophosphamide. Close monitoring is essential during treatment to manage potential side effects.
General data about CICLOFOSFAMIDA DR REDDY'S 500mg / ml
- Substance:
- cyclophosphamide
- Date of latest medicines list:
- 01-06-2026
- Product code:
- W68691001
- Concentration:
- 500mg / ml
- Pharmaceutical form:
- concentrate for solution for injection / infusion
- Quantity:
- 1
- Product type:
- Generic medicine
- Price:
- 275.17 RON
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for cyclophosphamide
Concentrations available for cyclophosphamide
- 1000mg
- 1000mg/2ml
- 1g
- 2000mg
- 2000mg/4ml
- 200mg
- 200mg/ml
- 500mg
- 500mg/ml
- 50mg
Compensation lists for CICLOFOSFAMIDA DR REDDY'S 500mg / ml Dr. Reddy's
G17 (C1) - Major collagenosis (systemic lupus erythematosus, scleroderma)
- Price
- 275.17 RON
- Copayment
- 275.17 RON
- Patient
- 0.00 RON
GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)
- Price
- 275.17 RON
- Copayment
- 275.17 RON
- Patient
- 0.00 RON
NHP 9.4 (C2) - Kidney transplant, combined kidney and pancreas transplant
- Price
- 275.17 RON
- Copayment
- 275.17 RON
- Patient
- 0.00 RON